 |
 |
|
|
|
| Salcitonin Acetate |
 |
| C145H240N44O48S2 |
 |
| 47931-85-1 |
 |
| It is clinically used to treat senile osteoporosis, post-menopause osteoporosis, fracture, deformed osteitis, neurogenic and dystrophic diseases, and hypercalcemia induced by metastatic tumor of bone. |
 |
Parameters of Product:
1 .Appearance :White powder
2 .Water Content(Karl Fischer) :≤6.0%
3 .Acetate Content(by HPLC) :≤13.0%
4 .Amino Acid Composition :±10% of theoretical
5 .Purity (by HPLC) :≥98.0%
6 .Single Impurity(by HPLC) :≤1.0%
7 .Peptide Content(by %N) :≥80%
8 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0%
9 .Bacterial Endotoxins :≤5EU/mg
|
|
|
|
|
|
